MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,517 | -71.8% | 53,162 | -27.0% | 0.00% | – |
Q2 2023 | $239,633 | +60.0% | 72,837 | +99.8% | 0.00% | – |
Q1 2023 | $149,810 | -27.4% | 36,450 | +3.6% | 0.00% | – |
Q4 2022 | $206,208 | -10.0% | 35,189 | +3.8% | 0.00% | – |
Q3 2022 | $229,000 | +57.9% | 33,887 | +7.4% | 0.00% | – |
Q2 2022 | $145,000 | +43.6% | 31,546 | +24.7% | 0.00% | – |
Q1 2022 | $101,000 | -35.3% | 25,295 | +0.7% | 0.00% | – |
Q4 2021 | $156,000 | -33.9% | 25,114 | 0.0% | 0.00% | – |
Q3 2021 | $236,000 | +24.2% | 25,114 | +79.3% | 0.00% | – |
Q2 2021 | $190,000 | -10.4% | 14,006 | +6.9% | 0.00% | – |
Q1 2021 | $212,000 | -41.4% | 13,097 | -3.7% | 0.00% | – |
Q4 2020 | $362,000 | +42.0% | 13,605 | -0.7% | 0.00% | – |
Q3 2020 | $255,000 | -26.5% | 13,702 | -7.5% | 0.00% | – |
Q2 2020 | $347,000 | +1185.2% | 14,818 | +213.6% | 0.00% | – |
Q1 2020 | $27,000 | -20.6% | 4,725 | -21.2% | 0.00% | – |
Q4 2019 | $34,000 | +277.8% | 5,995 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -62.5% | 5,995 | 0.0% | 0.00% | – |
Q2 2019 | $24,000 | +140.0% | 5,995 | +210.1% | 0.00% | – |
Q1 2019 | $10,000 | +25.0% | 1,933 | 0.0% | 0.00% | – |
Q4 2018 | $8,000 | -57.9% | 1,933 | 0.0% | 0.00% | – |
Q3 2018 | $19,000 | -45.7% | 1,933 | 0.0% | 0.00% | – |
Q2 2018 | $35,000 | +12.9% | 1,933 | -1.1% | 0.00% | – |
Q1 2018 | $31,000 | +158.3% | 1,955 | +178.1% | 0.00% | – |
Q4 2017 | $12,000 | 0.0% | 703 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | – | 703 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |